Privileged Scaffolds for Drug Design and Activity Improvement-Part I

Author(s): Yongtao Duan, Hai-liang Zhu

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 28 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Huang, H.; Song, C.; Chang, J. Synthesis and biological activity study of tanshinone derivatives: a literature and patent review. Curr. Top. Med. Chem., 2020, 20(28), 2520-2534.
[2]
Zhang, Z.; Shu, B.; Zhang, Y.; Deora, G.S.; Li, Q-S. 2,4,5-Trisubstituted thiazole: a privileged scaffold in drug design and activity improvement. Curr. Top. Med. Chem., 2020, 20(28), 2535-2577.
[3]
Xu, C.; Fang, M-Y.; Wang, K.; Liu, J.; Tai, G-P.; Zhang, Z-T.; Ruan, B-F. Discovery and development of inflammatory inhibitors from 2-phenylchromonone (flavone) scaffolds. Curr. Top. Med. Chem., 2020, 20(28), 2578-2598.
[4]
Mao, Y.; Soni, K.; Sangani, C.; Yao, Y. An overview of privileged scaffold: quinolines and isoquinolines in medicinal chemistry as anticancer agents. Curr. Top. Med. Chem., 2020, 20(28), 2599-2633.
[5]
Li, D-D.; Yu, P.; Xiao, W.; Wang, Z-Z.; Zhao, L-G. Berberine: a promising natural isoquinoline alkaloid for development of hypolipidemic drug. Curr. Top. Med. Chem., 2020, 20(28), 2634-2647.


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 28
Year: 2020
Page: [2519 - 2519]
Pages: 1
DOI: 10.2174/156802662028201021110151

Article Metrics

PDF: 19
HTML: 4
EPUB: 1
PRC: 1